Treace Medical Concepts, Inc. (TMCI)
Automate Your Wheel Strategy on TMCI
With Tiblio's Option Bot, you can configure your own wheel strategy including TMCI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TMCI
- Rev/Share 3.3644
- Book/Share 1.6811
- PB 3.4144
- Debt/Equity 0.6585
- CurrentRatio 4.5038
- ROIC -0.2993
- MktCap 361074700.0
- FreeCF/Share -0.5898
- PFCF -9.7701
- PE -6.7878
- Debt/Assets 0.337
- DivYield 0
- ROE -0.4869
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | TMCI | BTIG Research | Neutral | Buy | -- | $16 | Feb. 4, 2025 |
| Initiation | TMCI | Lake Street | -- | Buy | -- | $14.5 | Dec. 31, 2024 |
| Resumed | TMCI | JP Morgan | -- | Neutral | -- | $8 | Dec. 17, 2024 |
News
The Gross Law Firm Reminds Treace Medical Concepts, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025 - TMCI
Published: April 21, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , April 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI). Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Read More
Levi & Korsinsky Reminds Treace Medical Concepts, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025 - TMCI
Published: April 20, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 20, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=144118&wire=1 or contact Joseph E. Levi, Esq.
Read More
Levi & Korsinsky Notifies Treace Medical Concepts, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - TMCI
Published: April 20, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 20, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=144109&wire=1 or contact Joseph E. Levi, Esq.
Read More
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI
Published: April 20, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / April 20, 2025 / WHY: New York, N.Y., April 20, 2025.
Read More
Investors Who Lost Money on Treace Medical Concepts, Inc. (TMCI) Should Contact Levi & Korsinsky About Pending Class Action - TMCI
Published: April 18, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 18, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=143931&wire=1 or contact Joseph E. Levi, Esq.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
Published: April 18, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc.("Treace Medical" or the "Company") (NASDAQ:TMCI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Levi & Korsinsky Reminds Treace Medical Concepts, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025 – TMCI
Published: April 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc." or the "Company") (NASDAQ: TMCI) of a class action securities lawsuit.
Read More
June 10, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - TMCI
Published: April 18, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 18, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=143884&wire=1 or contact Joseph E. Levi, Esq.
Read More
Shareholders That Lost Money on Treace Medical Concepts, Inc. (TMCI) Should Contact Levi & Korsinsky About Pending Class Action - TMCI
Published: April 17, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 17, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=143683&wire=1 or contact Joseph E. Levi, Esq.
Read More
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Treace Medical Concepts, Inc. (TMCI) Investors To Inquire About Securities Fraud Class Action
Published: April 17, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI) securities between May 8, 2023 and May 7, 2024, inclusive (the “Class Period”). Treace Medical investors have until June 10, 2025 to file a lead plaintiff motion. IF YOU SUFFERED.
Read More
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 10, 2025 in Treace Medical Concepts, Inc. Lawsuit - TMCI
Published: April 16, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 16, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=143459&wire=1 or contact Joseph E. Levi, Esq.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
Published: April 16, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc.("Treace Medical" or the "Company") (NASDAQ:TMCI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Treace Medical Concepts, Inc. (TMCI) Shareholders
Published: April 16, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 16, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=143453&wire=1 or contact Joseph E. Levi, Esq.
Read More
TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: April 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Treace Medical Concepts, Inc. (“Treace Medical” or “the Company”) (NASDAQ: TMCI) and certain of its officers.
Read More
Levi & Korsinsky Reminds Treace Medical Concepts, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025 - TMCI
Published: April 16, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 16, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=143439&wire=1 or contact Joseph E. Levi, Esq.
Read More
TMCI Investors Have the Opportunity to Lead the Treace Medical Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Published: April 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Treace Medical To Contact Him Directly To Discuss Their Options
Read More
Treace Medical Concepts, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; June 10, 2025 Deadline to file Lead Plaintiff Motion
Published: April 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
Investors can contact the law firm at no cost to learn more about recovering their losses
Read More
Investors Who Lost Money on Treace Medical Concepts, Inc. (TMCI) Should Contact Levi & Korsinsky About Pending Class Action - TMCI
Published: April 15, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 15, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=143197&wire=1 or contact Joseph E. Levi, Esq.
Read More
TMCI Investors with Losses in Excess of $100K Have Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit
Published: April 15, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , April 15, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ: TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.
Read More
Levi & Korsinsky Notifies Shareholders of Treace Medical Concepts, Inc. (TMCI) of a Class Action Lawsuit and an Upcoming Deadline
Published: April 15, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 15, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=143183&wire=1 or contact Joseph E. Levi, Esq.
Read More
TMCI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: April 15, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / April 15, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Treace Medical Concepts, Inc. ("Treace Medical" or "the Company") (NASDAQ:TMCI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Treace Medical securities between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period").
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
Published: April 15, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc.("Treace Medical" or the "Company")(NASDAQ:TMCI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Rosen Law Firm Urges Treace Medical Concepts, Inc. (NASDAQ: TMCI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Published: April 15, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ: TMCI) between May 8, 2023 and May 7, 2024. Treace Medical describes itself as a “medical technology company focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities.” For more information, submit a form, email attorney Phillip Kim, or g.
Read More
Levi & Korsinsky Reminds Shareholders of an Investigation into Treace Medical Concepts, Inc. (TMCI) Regarding Potential Securities Fraud Allegations
Published: April 15, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc.") (NASDAQ:TMCI) concerning possible violations of federal securities laws. After the market closed on May 7, 2024, Treace released its first quarter 2024 financial results and revised its full year 2024 guidance, lowering it by approximately $20 million.
Read More
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)
Published: April 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Middle District of Florida against Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI), and certain of its former and current officers and/or directors (collectively, “Defendants”). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b-5) on …
Read More
Treace Medical Concepts, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - TMCI
Published: April 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc.") (NASDAQ:TMCI) concerning possible violations of federal securities laws. After the market closed on May 7, 2024, Treace released its first quarter 2024 financial results and revised its full year 2024 guidance, lowering it by approximately $20 million.
Read More
Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference
Published: March 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty ® and Adductoplasty ® Procedures, today announced the presentation of updated interim data for the ALIGN3D™ and Mini3D™ Lapiplasty® clinical studies, as well as the first presentation of the MTA3D™ Adductoplasty® clinical study, at the 2025 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting in Phoenix, Arizona.
Read More
An Investigation Has Been Launched Into Treace Medical Concepts, Inc. For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm
Published: February 28, 2025 by: Accesswire
Sentiment: Neutral
LOS ANGELES, CA / ACCESS Newswire / February 28, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation
Published: February 25, 2025 by: Accesswire
Sentiment: Neutral
LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
An Investigation Has Been Launched Into Treace Medical Concepts, Inc. For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm
Published: February 24, 2025 by: Accesswire
Sentiment: Neutral
LOS ANGELES, CA / ACCESS Newswire / February 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
About Treace Medical Concepts, Inc. (TMCI)
- IPO Date 2021-04-23
- Website https://www.treace.com
- Industry Medical - Devices
- CEO Mr. John T. Treace
- Employees 477